Literature DB >> 12525671

Erectile dysfunction.

Ridwan Shabsigh1, Aristotelis G Anastasiadis.   

Abstract

Erectile dysfunction (ED) is a highly prevalent and often undertreated condition. It may be a symptom of underlying, chronic illness and can have a negative impact on quality of life, psychosocial health, and relationships. The aging of the population, as well as the introduction of new treatment options, such as sildenafil, has led to increased public awareness of this disorder. New oral therapeutic agents are on the horizon. This article provides an overview of the physiology of erection, the pathophysiology of ED, and modern patient evaluation. Management options, including traditional therapeutic approaches as well as the new generation of oral agents, are also presented.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12525671     DOI: 10.1146/annurev.med.54.101601.152212

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  12 in total

Review 1.  [A discussion of the differential diagnosis of the impaired erection].

Authors:  G A Schaefer; C J Ahlers
Journal:  Urologe A       Date:  2006-08       Impact factor: 0.639

2.  Prevalence and risk factors of erectile dysfunction in Niger delta region, Nigeria.

Authors:  A U Idung; F Abasiubong; I A Ukott; S B Udoh; B C Unadike
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

3.  Effects of the aqueous and hexane extracts of Mondia whitei on the sexual behaviour and some fertility parameters of sexually inexperienced male rats.

Authors:  Pierre Watcho; Fabien Zelefack; Télesphore Benoît Nguelefack; Silvère Ngouela; Phelix Bruno Telefo; Pierre Kamtchouing; Etienne Tsamo; Albert Kamanyi
Journal:  Afr J Tradit Complement Altern Med       Date:  2006-08-28

Review 4.  Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management.

Authors:  Kalyana C Nandipati; Rupesh Raina; Ashok Agarwal; Craig D Zippe
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Correlation between penile cavernosal artery blood flow and retinal vascular findings in arteriogenic erectile dysfunction.

Authors:  Ahmed M Emarah; Shawky M El-Haggar; Ihab A Osman; Abdel Wahab S Khafagy
Journal:  Clin Ophthalmol       Date:  2010-09-20

Review 6.  Therapy of ED: PDE-5 Inhibitors.

Authors:  Ridwan Shabsigh
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 7.  Treatment of benign prostatic hyperplasia in hypertensive men.

Authors:  William B White; Timothy Moon
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

8.  Erectile dysfunction in qatar: prevalence and risk factors in 1,052 participants-a pilot study.

Authors:  Abdulla Al Naimi; Ahmad A Majzoub; Raidh A Talib; Onder Canguven; Abdulla Al Ansari
Journal:  Sex Med       Date:  2014-06       Impact factor: 2.491

Review 9.  Testosterone for the aging male; current evidence and recommended practice.

Authors:  Roger D Stanworth; T Hugh Jones
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  Markers of erectile dysfunction.

Authors:  Kelvin P Davies; Arnold Melman
Journal:  Indian J Urol       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.